Mutual Fund Research

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

As on Apr-22-2024 change fund
25.93  up0.28 (1.09%)

fund objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)9.9916.1218.2216.3626.45
Net Assets(Rs Crores) (as on 31-Mar-2024) 170.68 454.91 515.33 428.44 699.55
Scheme Returns(%)(Absolute)-0.1063.4912.40-10.2661.38
B'mark Returns(%)(Absolute)NANANANANA
Category Rank6/7555/7549/7570/7611/90
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2023-202416.3812.0810.6412.03
2022-2023-10.766.09-0.58-4.61
2021-202216.324.91-0.15-7.23
2020-202125.1321.847.88-1.89
2019-2020NANA5.95-6.46
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...15.74 
Cipla Ltd.8.31 
Torrent Pharmaceuticals Ltd.7.24 
Apollo Hospitals Enterprise Ltd.6.72 
Zydus Lifesciences Ltd.4.46 
Fortis Healthcare Ltd.4.37 
Ajanta Pharma Ltd.4.16 
Lupin Ltd.3.80 
Gland Pharma Ltd.3.59 
Alkem Laboratories Ltd.3.52 

Category

Sector Funds

Launch Date

10-Jul-19

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

699.55

portfolio price to book value

7.34

investing style?

Large Growth

fund manager?

Dhaval Shah

inception date (regular plan)

10-Jul-19

expense ratio (regular plan) %

2.37

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs74.35
Hospital & Healthcare Services15.35
Insurance1.90
Business Support1.04
Chemicals0.40

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019699.5553.4314.19NANA22.01
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20183,772.3257.0817.4324.39NA21.21
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19992,626.3451.4017.2623.1215.4516.06
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20182,352.3249.2315.9825.59NA24.17
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015878.7050.5515.7422.09NA11.52
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20047,125.2850.1715.5722.6616.9020.71
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20182,235.1546.6314.8223.57NA21.28
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005947.2648.0113.4620.8913.6617.97
LIC MF Healthcare Fund-Reg(G)Large-Growth 28-Feb-201961.6944.6910.7518.80NA18.41
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021160.3944.95NANANA12.79
HDFC Pharma and Healthcare Fund-Reg(G)Large-Growth 04-Oct-2023800.65NANANANA23.86
WOC Pharma and Healthcare Fund-Reg(G)Large-Growth 06-Feb-2024108.61NANANANA-0.30
Kotak Healthcare Fund-Reg(G)Large-Growth 11-Dec-2023284.18NANANANA11.42
Quant Healthcare Fund-Reg(G)Large-Growth 17-Jul-2023264.51NANANANA36.05
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Tel : 22702326
Email id : assist@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Subscribe

For all the Latest Market News, Investment Ideas.

Follow us

AMFI Registration No:88227

A Reliabull Financial Services Venture

Designed & Developed by  Accord Fintech Pvt. Ltd.